Drug Therapy Alternatives in the Treatment of Thyroid Cancer
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (6) , 801-812
- https://doi.org/10.2165/00003495-199855060-00007
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Medullary Thyroid Carcinoma: Recent Advances and Management UpdateThyroid®, 1995
- The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre studyJournal of Internal Medicine, 1995
- Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid CarcinomaClinical Nuclear Medicine, 1988
- Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid CancerNew England Journal of Medicine, 1983
- Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy a new approachCancer, 1983
- Feasibility of Low Doses of l-131 for Thyroid Ablation in Postsurgical Patients with Thyroid CarcinomaClinical Nuclear Medicine, 1981
- Radioiodine I-131 therapy in the management of thyroid cancer.A prospective studyCancer, 1977